A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow.
about
Can animal models of disease reliably inform human studies?Publication bias in reports of animal stroke studies leads to major overstatement of efficacyNitric oxide and peroxynitrite in health and diseaseEffects of NXY-059 in experimental stroke: an individual animal meta-analysisPotential Roles of Adropin in Central Nervous System: Review of Current LiteratureEndothelial nitric oxide synthase: a potential therapeutic target for cerebrovascular diseasesAuthorization of Animal Experiments Is Based on Confidence Rather than Evidence of Scientific RigorTherapeutic Potential of Transdermal Glyceryl Trinitrate in the Management of Acute Stroke.NOSH-NBP, a Novel Nitric Oxide and Hydrogen Sulfide- Releasing Hybrid, Attenuates Ischemic Stroke-Induced Neuroinflammatory Injury by Modulating Microglia PolarizationThe contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicityStatistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial.Soluble guanylate cyclase alpha1beta1 limits stroke size and attenuates neurological injury.Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.A blinded, randomized study of L-arginine in small clot embolized rabbitsThe use of systematic reviews and reporting guidelines to advance the implementation of the 3Rs.Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia.Nitric oxide: considerations for the treatment of ischemic stroke.Determining the Feasibility of Ambulance-Based Randomised Controlled Trials in Patients with Ultra-Acute Stroke: Study Protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT, ISRCTN66434824)Estrogens and experimental ischemic stroke: a systematic review.Bench to bedside: the quest for quality in experimental stroke research.Following experimental stroke, the recovering brain is vulnerable to lipoxygenase-dependent semaphorin signalingTemporal profiles of blood pressure, circulating nitric oxide, and adrenomedullin as predictors of clinical outcome in acute ischemic stroke patientsEffect of Treatment Delay, Stroke Type, and Thrombolysis on the Effect of Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome after Acute Stroke: A Systematic Review and Meta-Analysis of Individual Patient from Randomised Trials.Systematic reviews as a tool for planning and interpreting trials.Emulating multicentre clinical stroke trials: a new paradigm for studying novel interventions in experimental models of stroke.Cerebral blood flow alteration in neuroprotection following cerebral ischaemia.Targeting gaseous molecules to protect against cerebral ischaemic injury: mechanisms and prospects.Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury.L-arginine and nitric oxide in CNS function and neurodegenerative diseases.Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053).Parasympathetic innervation of vertebrobasilar arteries: is this a potential clinical target?Beneficial effects of L-arginine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuronal degeneration in substantia nigra of Balb/c mice.Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122).Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?Neuroprotection by combination of resveratrol and enriched environment against ischemic brain injury in rats.Granulocyte-Colony Stimulating Factor Increases Cerebral Blood Flow via a NO Surge Mediated by Akt/eNOS Pathway to Reduce Ischemic Injury.The Janus Face of VEGF in Stroke.Neuroprotectants in the Era of Reperfusion Therapy.
P2860
Q21563449-2A4BA8D2-B4BE-4677-85AA-7F3D3FAFD629Q24273209-78C6A130-6523-49EC-9EF3-597901BCE299Q24645400-9FD59DBF-E5CC-4106-8CC4-3BD1F78346E4Q24654761-25DF3AEF-AB6E-43CA-94A9-5DDDFEE17639Q26742073-854B228E-EA5D-4A04-B535-11F19CCE6FC3Q26752894-831D8682-C700-4E52-A68B-9B67E382A7DEQ28590246-0A396A30-AE92-47BF-8298-73DCA19F0F61Q30490373-ADA3A1FF-9155-418F-88F3-FF2A6C6802E8Q33729382-BDFF6708-3011-4265-8A89-9D68AFEEBA97Q34504984-B2609B5C-D4B1-48F2-93A3-3275F1BAF2B1Q34531759-61F39A69-3861-424E-B52B-F47283D973B8Q34618219-FED7D1F9-1532-43BB-B202-586EC91D99EAQ35129507-558E07EA-CBA9-4E27-9253-5EC90C6C3BFBQ35243300-69D17FEF-0722-43ED-9323-CD8549135235Q35244647-16E8A16B-8886-4DB8-90C8-117620091183Q35652254-8871DDE7-290E-49E1-BD96-665E9550FC9CQ36079329-562E2688-6B79-4948-BAD8-60CB63C08E7FQ36344183-CEF3E020-BFD3-4E5D-98B7-6161E4BCF177Q36377761-939269F5-DED5-4A58-80D8-34B0387F9602Q36416843-9DC79CD9-E7AD-4F42-8705-B17FC9FFEAF4Q36534341-45B920C0-D2E8-4E40-AF0A-2585D021BAEDQ36817489-82A6ECD8-D005-47C9-8EE2-09464C1AA808Q36854734-D2783D80-0B2E-4EFE-9BF6-3BED61760879Q37399439-47C69619-7916-4E4A-8191-03A3C6981AEEQ37636343-AF661258-1025-4223-8785-FA3D18E5CF83Q37895012-E1FAA4BA-68B2-4F50-B987-0444517E9D93Q37965856-FD7C51DC-E008-4210-916C-A4329EC28917Q37971308-5E0FABBC-B4FE-40C5-AF84-638DC7ECE277Q38030379-48AA0A6F-05B9-4978-A9B3-0AEF0F41A9B2Q38134415-15353D35-CDB8-438F-98CA-74339AE1EE76Q38649591-0B645D2E-6B65-406B-9113-683EB4AABAFDQ38880941-DE462E49-665E-4ADA-A68B-70AEFDA74063Q41108404-F0E5932A-ACB7-43B1-9FA6-F3A215AE8451Q46427557-93A73AAD-B312-4B84-A757-46D22840E8A9Q48189466-438568B6-1BE4-499E-83DD-9E461DDC3278Q48901542-22D7D979-16BD-409D-8ABA-736DEBFA44EEQ53439244-6B175837-D2A5-4C95-BD1C-40AAC55573A9Q55078229-C990400B-359E-4231-BF55-A182B59439FFQ55261150-1A5FFA3A-45D1-4ED2-B244-C13B6BB7D41C
P2860
A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
A systematic review of nitric ...... size and cerebral blood flow.
@ast
A systematic review of nitric ...... size and cerebral blood flow.
@en
type
label
A systematic review of nitric ...... size and cerebral blood flow.
@ast
A systematic review of nitric ...... size and cerebral blood flow.
@en
prefLabel
A systematic review of nitric ...... size and cerebral blood flow.
@ast
A systematic review of nitric ...... size and cerebral blood flow.
@en
P2093
P1433
P1476
A systematic review of nitric ...... t size and cerebral blood flow
@en
P2093
Claire Gibson
Laura Gray
Mark Willmot
Sean Murphy
P304
P356
10.1016/J.NIOX.2005.01.003
P577
2005-05-01T00:00:00Z